Janney Montgomery Scott Downgrades Innocoll (INNL) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. HD
3. AMLX
4. METC
5. SPY
6. DOO
7. ARGX
8. KLAR
9. INFQ

December 30, 2016 6:35 AM EST
Get Alerts INNL Hot Sheet
Price: $2.35 --0%

Rating Summary:
    2 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE

Janney Montgomery Scott downgraded Innocoll (NASDAQ: INNL) from Buy to Neutral with a fair value target of $2.00 after the company received a Refusal to File letter from the United States Food and Drug Administration (FDA) for XARACOLL, the company’s product candidate for the treatment of postsurgical pain.

For an analyst ratings summary and ratings history on Innocoll click here. For more ratings news on Innocoll click here.

Shares of Innocoll closed at $1.77 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Janney Montgomery Scott, FDA